Combination vigabatrin and lamotrigine therapy for intractable epilepsy

Seizure

Volumn 5, Issue 1, 1996, Pages 51-56

  Schapel, Graham J ^a,b   Black, Andrew B ^a   Lam, Esther L ^a   Robinson, Martin ^a   Dollman, William B ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Additive antiepileptic efficacy; Combination therapy; Intractable epilepsy; Lamotrigine; Vigabatrin

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; LAMOTRIGINE; PHENYTOIN; PRIMIDONE; VALPROIC ACID; VIGABATRIN;

ABDOMINAL DISTENSION; ABSENCE; ADOLESCENT; ADULT; AGGRESSION; AMNESIA; ANOREXIA; ARTICLE; ATAXIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DELUSION; DEPRESSION; DIPLOPIA; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DYSARTHRIA; FEMALE; HEADACHE; HUMAN; INTRACTABLE EPILEPSY; LEG EDEMA; MALE; NAUSEA; OBESITY; PANCYTOPENIA; PERSONALITY DISORDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMOTOR RETARDATION; RASH; SEIZURE; STATISTICAL ANALYSIS; TREMOR; VOMITING;

EID: 0029867298     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(96)80063-X     Document Type: Article

References (12)

1. Hauser, W.A., Hesdorffer, D.C. Epilepsy: frequency, causes and consequences. Prognosis. New York, Demos Publications 1990, pp. 197-243.
2. Blume, W.T., Aicardi, J. and Dreifuss, F.E. Syndromes not amenable to resective surgery. In: (Ed. J. Engel Jr.) Surgical treatment of the epilepsies. New York, Raven Press 1993, pp. 103-118.
3. Patsalos, P.N. and Duncan, J.S. New antiepileptic drugs. A review of their current status and clinical potential. CNS Drugs 1994; 2: 40-77.
4. Sander, J.W.A.S., Patsalos, P.N., Oxley, J.R., Hamilton, M.J. and Yuen, A.W.C. A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Research 1990; 6: 221-226.
5. Schapel, G.J., Beran, R.G., Vajda, F.J.E. et al. Double-blind, placebo-controlled crossover study of lamotrigine in treatment resistant partial seizures. Journal of Neurology, Neurosurgery and Psychiatry 1993; 56: 448-453.
6. Michelucci, R. and Tassinari, C.A. Response to vigabatrin in relation to seizure type. British Journal of Pharmacology 1989; 27: 119S-124S.
7. Kirker, S. and Reynolds, E.H. Vigabatrin and lamotrigine in a patient with intractable epilepsy. Acta Neurollogica Scandinavica 1990; 133 (Suppl.): 38-39.
8. BMDP Statistical Software Manual. Berkley, University of California Press, 1990, pp. 429.
9. Schmidt, D. Diagnostic and therapeutic management of intractable epilepsy. In: (Eds D. Schmidt and P.L. Morselli) Intractable epilepsy. New York, Raven Press, 1986, pp. 237-257.
10. Stolarck, I., Blacklaw, J., Forrest, G. and Brodie, M.J. Vigabatrin and lamotrigine in refractory epilepsy. Journal of Neurology Neurosurgery and Psychiatry 1994; 57: 921-924.
11. Cohen, A.F., Ashby, L., Crowley, D., Land, G., Peck, A.W. and Miller, A.A. Lamotrigine (BW 430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam, British Journal of Clinical Pharmacology 1985; 20: 619-629.
12. Ferrie, C.D. and Panayiotopoulas, C.P. Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsy. Seizure 1994; 3: 157-159.